Literature DB >> 20223879

Genetic and functional analysis of human P2X5 reveals a distinct pattern of exon 10 polymorphism with predominant expression of the nonfunctional receptor isoform.

Smita Kotnis1, Brendan Bingham, Dmitry V Vasilyev, Scott W Miller, Yuchen Bai, Sarita Yeola, Pranab K Chanda, Mark R Bowlby, Edward J Kaftan, Tarek A Samad, Garth T Whiteside.   

Abstract

P2X5 is a member of the P2X family of ATP-gated nonselective cation channels, which exist as trimeric assemblies. P2X5 is believed to trimerize with another member of this family, P2X1. We investigated the single-nucleotide polymorphism (SNP) at the 3' splice site of exon 10 of the human P2X5 gene. As reported previously, presence of a T at the SNP location results in inclusion of exon 10 in the mature transcript, whereas exon 10 is excluded when a G is present at this location. Our genotyping of human DNA samples reveals predominance of the G-bearing allele, which was exclusively present in DNA samples from white American, Middle Eastern, and Chinese donors. Samples from African American donors were polymorphic, with the G allele more frequent. Reverse transcription-polymerase chain reaction analysis of lymphocytes demonstrated a 100% positive correlation between genotype and P2X5 transcript. Immunostaining of P2X1/P2X5 stably coexpressing cell lines showed full-length P2X5 to be expressed at the cell surface and the exon 10-deleted isoform to be cytoplasmic. Fluorometric imaging-based pharmacological characterization indicated a ligand-dependent increase in intracellular calcium in 1321N1 astrocytoma cells transiently expressing full-length P2X5 but not the exon 10-deleted isoform. Likewise, electrophysiological analysis showed robust ATP-evoked currents when full-length but not the exon 10-deleted isoform of P2X5 was expressed. Taken together, our findings indicate that most humans express only a nonfunctional isoform of P2X5, which is in stark contrast to what is seen in other vertebrate species in which P2X5 has been studied, from which only the full-length isoform is known.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223879     DOI: 10.1124/mol.110.063636

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

Review 2.  Activation and regulation of purinergic P2X receptor channels.

Authors:  Claudio Coddou; Zonghe Yan; Tomas Obsil; J Pablo Huidobro-Toro; Stanko S Stojilkovic
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

Review 3.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

4.  Altered allostery of the left flipper domain underlies the weak ATP response of rat P2X5 receptors.

Authors:  Liang-Fei Sun; Yan Liu; Jin Wang; Li-Dong Huang; Yang Yang; Xiao-Yang Cheng; Ying-Zhe Fan; Michael X Zhu; Hong Liang; Yun Tian; Heng-Shan Wang; Chang-Run Guo; Ye Yu
Journal:  J Biol Chem       Date:  2019-11-14       Impact factor: 5.157

Review 5.  P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y₂ receptor interactions in neuroinflammation.

Authors:  Gary A Weisman; Jean M Camden; Troy S Peterson; Deepa Ajit; Lucas T Woods; Laurie Erb
Journal:  Mol Neurobiol       Date:  2012-04-01       Impact factor: 5.590

Review 6.  Molecular Pharmacology of P2X Receptors: Exploring Druggable Domains Revealed by Structural Biology.

Authors:  Adam C Oken; Ipsita Krishnamurthy; Jonathan C Savage; Nicolas E Lisi; Michael H Godsey; Steven E Mansoor
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

Review 7.  Rehabilitation of the P2X5 receptor: a re-evaluation of structure and function.

Authors:  Brian F King
Journal:  Purinergic Signal       Date:  2022-10-24       Impact factor: 3.950

8.  Identification of human P2X1 receptor-interacting proteins reveals a role of the cytoskeleton in receptor regulation.

Authors:  Ulyana Lalo; Jonathan A Roberts; Richard J Evans
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

Review 9.  The trafficking and targeting of P2X receptors.

Authors:  Lucy E Robinson; Ruth D Murrell-Lagnado
Journal:  Front Cell Neurosci       Date:  2013-11-22       Impact factor: 5.505

Review 10.  Update of P2X receptor properties and their pharmacology: IUPHAR Review 30.

Authors:  Peter Illes; Christa E Müller; Kenneth A Jacobson; Thomas Grutter; Annette Nicke; Samuel J Fountain; Charles Kennedy; Günther Schmalzing; Michael F Jarvis; Stanko S Stojilkovic; Brian F King; Francesco Di Virgilio
Journal:  Br J Pharmacol       Date:  2020-12-21       Impact factor: 9.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.